ASN Kidney Translation Series: ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives

The authors of the ASN Kidney Health Guidance on Potassium and Phosphorus Food additives discuss clinical approaches to managing hyperkalemia and CKD-mineral and bone disorder risks associated with food additives for people with kidney disease.

Drs. Anna Levin and Annika Wernerson discuss the findings from their study, "Transcriptomic Patterns in Adult and Pediatric Patients with IgA Nephropathy or IgA Vasculitis with Nephropathy," with JASN Deputy Editor David H. Ellison.

Drs. Shipra Agrawal and Monoj K. Das discuss the results of their study, "RNA Alternative Splicing and Polyadenylation and Regulation of the Glomerular Filtration Barrier," with JASN Deputy Editor Alan S.L. Yu and Junior Associate Editor Jason O. Wu.

Kidney Translation Podcast discusses cardiovascular and kidney disease studies: CKM syndrome stages and mortality prediction, cardiac risk prediction in patients with kidney failure undergoing noncardiac surgery, and SGLT2 inhibition in type 1 diabetes.

Dr. Ladan Golestaneh discusses the findings of her study, "Effect of Peer Mentorship on Hospitalizations among Patients Receiving Maintenance Hemodialysis: A Pragmatic Randomized Controlled Trial," with JASN Deputy Editor Manjula Kurella Tamura.

Dr. Shaifali Sandal and Saly El Wazze discuss the results of their study, "A Roadmap for Disaster Risk Reduction and Management in Kidney Care: A Scoping Review and Content Analysis," with JASN Deputy Editor Manjula Kurella Tamura.

Drs. David Pearce and John Demko discuss the results of their study, "Coordinated Regulation of Renal Glucose Reabsorption and Gluconeogenesis by mTORC2 and Potassium," with JASN Deputy Editor David H. Ellison.

Dr. Tobias Hermle and Dominik Spitz discuss the findings of their study, "A Drug-Screening Platform for Podocytopathies in Drosophila Nephrocytes," with JASN Deputy Editor Alan S.L. Yu.

On this ASN Kidney Translation Podcast, Dr. Matthew Sparks discusses key ADPKD studies: circadian clock disruption and cyst growth (JASN), depressive symptoms in adults with ADPKD (Kidney360), and biomarker-based kidney outcome prediction (CJASN).

Dr. Ziv Harel discusses findings from his study, "Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial," with JASN Deputy Editor Manjula Kurella Tamura.